Analysts’ Revisions Show Improving Sentiment For Galera Therapeutics Inc (NASDAQ: GRTX)

Galera Therapeutics Inc (NASDAQ:GRTX) price closed lower on Friday, May 03, dropping -3.93% below its previous close.

A look at the daily price movement shows that the last close reads $0.19. Taking into account the 52-week price action we note that the stock hit a 52-week high of $3.59 and 52-week low of $0.09. The stock added 14.81% on its value in the past month.

Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give GRTX a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a Hold, while an average of long term indicators are currently assigning the stock as Hold.

The overview shows that GRTX’s price is at present 4.10% off the SMA20 and -6.49% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 50.03, with weekly volatility standing at 9.92%. The indicator jumps to 12.00% when calculated based on the past 30 days. Galera Therapeutics Inc (NASDAQ:GRTX)’s beta value is holding at 2.03, while the average true range (ATR) indicator is currently reading 0.02.

An analysis of the Galera Therapeutics Inc (NASDAQ:GRTX) stock in terms of its daily trading volume indicates that the 3-month average is 2.07 million.

Current records show that the company has 54.39M in outstanding shares. The insiders’ percentage holdings are 25.03% of outstanding shares while the percentage share held by institutions stands at 14.77%. But the 27.92% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.

Most Popular